Abstracts of the Coral Snake Antivenom Conference, January 28, 2009: Sponsored by the Office of Rare Diseases, National Institutes of Health Organized by the Center for Biologics Evaluation and Research, US Food and Drug Administration January 28, 2009, Rockville, MD

Steven A Seifert

doi:10.1007/BF03178276

. 2009 Dec;5(4):250–256. doi: 10.1007/BF03178276

Abstracts of the Coral Snake Antivenom Conference, January 28, 2009

Sponsored by the Office of Rare Diseases, National Institutes of Health Organized by the Center for Biologics Evaluation and Research, US Food and Drug Administration January 28, 2009, Rockville, MD

Steven A Seifert

PMCID: PMC3550400

Full Text

The Full Text of this article is available as a PDF (94.0 KB).

References

1.Code of Federal Regulations: 21 CFR Part 312, Subpart B, (21 CFR 312. 34–35)
2.At www.fda.gov/oashi/fast/html (accessed February 11, 2009)

[CR1] 1.Code of Federal Regulations: 21 CFR Part 312, Subpart B, (21 CFR 312. 34–35)

[CR2] 2.At www.fda.gov/oashi/fast/html (accessed February 11, 2009)

PERMALINK

Abstracts of the Coral Snake Antivenom Conference, January 28, 2009

Steven A Seifert, MD, FACMT, FAACT

Full Text

References

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

Abstracts of the Coral Snake Antivenom Conference, January 28, 2009

Steven A Seifert, MD, FACMT, FAACT

Full Text

References

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases